172 related articles for article (PubMed ID: 27389864)
1. Clinicopathologic evaluation of cytopenic patients with isolated trisomy 8: a detailed comparison between idiopathic cytopenia of unknown significance and low-grade myelodysplastic syndrome.
Petrova-Drus K; Hasserjian R; Pozdnyakova O; Dal Cin P; Mathew S; Margolskee E; Orazi A; Geyer JT
Leuk Lymphoma; 2017 Mar; 58(3):569-577. PubMed ID: 27389864
[TBL] [Abstract][Full Text] [Related]
2. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients.
Yabe M; Medeiros LJ; Tang G; Wang SA; P Patel K; Routbort M; Bhagat G; Bueso-Ramos CE; Jorgensen JL; Luthra R; Chen W; Muzzafar T; Kanagal-Shamanna R; Khoury JD; Daneshbod Y; Davanlou M; Li S; Young KH; Miranda RN
Hum Pathol; 2016 Apr; 50():109-17. PubMed ID: 26997444
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface.
Wimazal F; Fonatsch C; Thalhammer R; Schwarzinger I; Müllauer L; Sperr WR; Bennett JM; Valent P
Leuk Res; 2007 Nov; 31(11):1461-8. PubMed ID: 17507091
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic cytopenia of undetermined significance and the minimal criteria for a diagnosis of myelodysplastic syndrome.
Pavlu J; Emmerson J; Marks AJ; Bain BJ
Leuk Lymphoma; 2011 Mar; 52(3):515-6. PubMed ID: 21323527
[TBL] [Abstract][Full Text] [Related]
5. ASXL1 is a molecular predictor in idiopathic cytopenia of undetermined significance.
Shin DY; Park JK; Kim SM; Im K; Kim JA; Kim SY; Hwang SM; Yoon SS; Lee DS
Leuk Lymphoma; 2019 Mar; 60(3):756-763. PubMed ID: 30301403
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Severe, Idiopathic Cytopenia of Undetermined Significance(ICUS)in an Elderly Patient].
Shinohara K
Gan To Kagaku Ryoho; 2016 Jul; 43(7):921-4. PubMed ID: 27431643
[TBL] [Abstract][Full Text] [Related]
7. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
8. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patients.
Schroeder T; Ruf L; Bernhardt A; Hildebrandt B; Aivado M; Aul C; Gattermann N; Haas R; Germing U
Ann Oncol; 2010 Nov; 21(11):2267-2271. PubMed ID: 20439346
[TBL] [Abstract][Full Text] [Related]
10. Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia.
Jajosky AN; Sadri N; Meyerson HJ; Oduro KA; Kelkar A; Fitzgerald B; Tomlinson B; Moore EM; Beck RC
Eur J Haematol; 2021 Apr; 106(4):500-507. PubMed ID: 33386622
[TBL] [Abstract][Full Text] [Related]
11. The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP).
Malcovati L; Cazzola M
Hematology Am Soc Hematol Educ Program; 2015; 2015():299-307. PubMed ID: 26637737
[TBL] [Abstract][Full Text] [Related]
12. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal Behcet's-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review.
Wesner N; Drevon L; Guedon A; Fraison JB; Terrier B; Trad S; Kahn JE; Aouba A; Gillard J; Ponsoye M; Hanslik T; Gourguechon C; Liozon E; Laribi K; Rossignol J; Hermine O; Seksik P; Adès L; Carrat F; Fenaux P; Mekinian A; Fain O;
Leuk Lymphoma; 2019 Jul; 60(7):1782-1788. PubMed ID: 30457024
[TBL] [Abstract][Full Text] [Related]
14. A novel complete blood count-based score to screen for myelodysplastic syndrome in cytopenic patients.
Boutault R; Peterlin P; Boubaya M; Sockel K; Chevallier P; Garnier A; Guillaume T; Le Bourgeois A; Debord C; Godon C; Le Bris Y; Theisen O; Kroschinsky F; Moreau P; Béné MC; Platzbecker U; Eveillard M
Br J Haematol; 2018 Dec; 183(5):736-746. PubMed ID: 30406952
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of Flow Cytometry Standardized Using the European LeukemiaNet for Myelodysplastic Syndrome.
Takeuchi A; Imataki O; Kubo H; Kondo A; Seo K; Uemura M; Yamaoka G; Murao K; Takeuchi A
Acta Haematol; 2020; 143(2):140-145. PubMed ID: 31330512
[TBL] [Abstract][Full Text] [Related]
16. Unexplained chronic cytopenia: is it idiopathic cytopenia of undetermined significance or myelodysplastic syndrome.
Ramachandran P; Erdinc B; Sahni S; Avezbakiyev B
BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31630129
[TBL] [Abstract][Full Text] [Related]
17. Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group.
Hebeda KM; Tzankov A; Boudova L; Saft L; Hasserjian RP; de Boer M; Fend F; Orazi A; Leguit R
Pathobiology; 2019; 86(1):62-75. PubMed ID: 29982244
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS.
Valent P; Bain BJ; Bennett JM; Wimazal F; Sperr WR; Mufti G; Horny HP
Leuk Res; 2012 Jan; 36(1):1-5. PubMed ID: 21920601
[TBL] [Abstract][Full Text] [Related]
19. Isolated trisomy 2 in bone marrows of patients with suspected hematopoietic malignancies.
Aypar U; Reichard KK; Waltman LA; Van Dyke DL
Cancer Genet; 2014 Apr; 207(4):124-7. PubMed ID: 24736057
[TBL] [Abstract][Full Text] [Related]
20. Single nucleotide polymorphism array-based karyotyping in acute myeloid leukemia or myelodysplastic syndrome with trisomy 8 as the sole chromosomal abnormality.
Hahm C; Mun YC; Seong CM; Han SH; Chung WS; Huh J
Acta Haematol; 2013; 129(3):154-8. PubMed ID: 23208021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
